A nanoparticle-based approach to improve the outcome of cancer active immunotherapy with lipopolysaccharides

This study sought to develop a simple nanoparticle-based approach to enhance the efficiency and tolerability of lipopolysaccharide (LPS), a potent ligand of Toll-like Receptor 4 (TLR4), for immunotherapy in cancer. Despite holding promise within this context, the strong pro-inflammatory properties o...

Descripción completa

Detalles Bibliográficos
Autores principales: Shetab Boushehri, Maryam A., Abdel-Mottaleb, Mona M. A., Béduneau, Arnaud, Pellequer, Yann, Lamprecht, Alf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058527/
https://www.ncbi.nlm.nih.gov/pubmed/29902933
http://dx.doi.org/10.1080/10717544.2018.1469684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058527/
https://www.ncbi.nlm.nih.gov/pubmed/29902933
http://dx.doi.org/10.1080/10717544.2018.1469684

Ejemplares similares